Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyma V Polimera

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cureus|July 25, 2019
A Case of Confirmed Ceftriaxone-induced Immune ThrombocytopeniaShady Piedra Abusharar, Neal Shah, Ravi Patel, et al.
Cureus|March 23, 2021
A Case of Cefepime-Induced Neurotoxicity: Renal Function Missing in ActionBrooke P Lichak, Omolara Lawal, Hyma V Polimera, et al.
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Management options for node-positive muscle-invasive bladder cancerHyma V Polimera, Priyanka Bhatia, Megan Wheelden, et al.
Clinics and Practice|July 17, 2020
Immune mediated necrotizing myopathy: A rare complication of statin therapyShady Piedra Abusharar, Prashanth Moku, Sharon Banks, et al.
International Journal of Cancer|June 21, 2018
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohortsAllan Lipton, Kim Leitzel, Suhail M Ali, et al.
Scientific Reports|December 26, 2019
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancerNicholas Willumsen, Suhail M Ali, Kim Leitzel, et al.
Cancer|February 20, 2024
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort studyCecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cureus|July 25, 2019
A Case of Confirmed Ceftriaxone-induced Immune ThrombocytopeniaShady Piedra Abusharar, Neal Shah, Ravi Patel, et al.
Cureus|March 23, 2021
A Case of Cefepime-Induced Neurotoxicity: Renal Function Missing in ActionBrooke P Lichak, Omolara Lawal, Hyma V Polimera, et al.
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Management options for node-positive muscle-invasive bladder cancerHyma V Polimera, Priyanka Bhatia, Megan Wheelden, et al.
Clinics and Practice|July 17, 2020
Immune mediated necrotizing myopathy: A rare complication of statin therapyShady Piedra Abusharar, Prashanth Moku, Sharon Banks, et al.
International Journal of Cancer|June 21, 2018
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohortsAllan Lipton, Kim Leitzel, Suhail M Ali, et al.
Scientific Reports|December 26, 2019
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancerNicholas Willumsen, Suhail M Ali, Kim Leitzel, et al.
Cancer|February 20, 2024
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort studyCecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Pageof 1